K. N. Khrapov

K. N. Khrapov

Auto-generated profile, based on publicly available information

K. N. Khrapov

Pavlov University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2021 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
KKK. N. Khrapov
K. N. Khrapov
AKA. A. Khryapa
A. A. Khryapa
IVI. V. Vartanova
I. V. Vartanova
SSS. S. Sedov
S. S. Sedov
YOYu. S. Okhapina
Yu. S. Okhapina
EGE. G. Gavrilova
E. G. Gavrilova
Представлен клинический случай развития анафилактического шока у пациента, которому планировали выполнить оперативное вмешательство на позвоночнике. Через 10 мин после введения в анестезию у пациента развились выраженная гипотензия (резистентная к введению адреномиметиков), тахикардия, снижение парциального давления углекислого газа в конце выдоха. Вследствие быстрого развития критического состояния, отсутствия специфических кожных проявлений и аллергологического анамнеза, а также прямой связи с введением конкретного агента потребовалось проводить дифференциальную диагностику между острым инфарктом миокарда, тромбоэмболией легочной артерии и анафилактическим шоком. На фоне проведения интенсивной терапии больному выполнили ЭКГ-исследование, эхокардиографию, анализ газового состава крови. Решающим диагностическим фактором оказалось выявление признаков бронхоспазма. При стабилизации состояния выполнили ангиографию сосудов сердца и легких, позднее был установлен агент, вызвавший развитие анафилаксии. Выявление причины гипотензии после индукции анестезии имеет решающее значение, поскольку терапия может существенно отличаться. Развитие анафилактического шока во время общей анестезии не является частым событием, но несвоевременная диагностика и задержка в проведении терапии могут привести к фатальному исходу. В статье на примере представленного клинического случая обсуждаются современные подходы к диагностике и терапии периоперационной анафилаксии.

29 December 2025 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Closed access
MKM. V. Kuzmina
M. V. Kuzmina
KKK. N. Khrapov
K. N. Khrapov
Introduction. Total hip arthroplasty is currently the standard treatment for end-stage osteoarthritis. However, this type of surgery is associated with the development of intense postoperative pain. Modern approaches to pain management are based on the principle of multimodal analgesia, which widely utilizes various methods of local anesthesia. The recent development of ultrasound technology and its integration into anesthesiology has significantly improved the safety and efficacy of peripheral nerve blocks. This review discusses the clinical efficacy of two popular peripheral nerve blocks used in multimodal analgesia regimens: the Fascia Iliaca Block and the Pericapsular Nerve Group Block. Materials and methods . The search for publications (1973–2024) was carried out in databases eLibrary.ru, PubMed, Google Scholar. A total of 50 publications were included, of which 45 were clinical studies. Conclusion. Current evidence generally confirms the effectiveness of using regional anesthesia techniques such as FIB and PENG block as a part of multimodal analgesia in patients after primary THA. This approach provides an opioid-sparing effect, reduces the risk of various complications, and promotes early mobilization. However, there are currently insufficient data to provide clear recommendations for most aspects of the application of these blocks.

28 August 2026 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
MKM. V. Kuzmina
M. V. Kuzmina
KKK. N. Khrapov
K. N. Khrapov
VMV. M. Miroshkina
V. M. Miroshkina
МКМ. В. Кузьмина
М. В. Кузьмина
КХК. Н. Храпов
К. Н. Храпов
ВМВ. М. Мирошкина
В. М. Мирошкина
Introduction . The development of ultrasound guidance has facilitated the implementation of selective regional analgesia techniques in clinical practice. One such technique is the pericapsular nerve group (PENG) block, which has emerged as a potential alternative to neuraxial analgesia for hip surgery.The objective was to compare the analgesic efficacy and safety profile of a single-shot PENG block with continuous epidural analgesia (EA) in patients undergoing primary total hip arthroplasty (THA). Materials and methods . A total of 100 patients undergoing primary THA were enrolled in this prospective randomized trial, 51 patients were assigned to the PENG block combined with a lateral femoral cutaneous nerve block group, and 49 patients to the continuous EA group. The primary endpoint was postoperative pain intensity assessed using a visual analogue scale (VAS) at rest and during movement. Secondary endpoints included opioid requirements, preservation of quadriceps muscle strength, and the incidence of complications. Results . Static VAS scores were significantly higher in the PENG group at 12 and 24 hours postoperatively (p < 0.001), whereas no differences were observed at 6 and 48 hours. Dynamic VAS was significantly higher in the EA group after 48 hours (4 [3.5–5] versus 3 [3–4]; p = 0.027). The proportion of patients not requiring opioids did not differ between groups (80.4% vs. 81.6%; p = 0.76). Quadriceps muscle strength was significantly better preserved in the PENG group at both 6 and 24 hours postoperatively (p < 0.001). Arterial hypotension was more often recorded in the EA group (24.5% vs. 5.9%; p = 0.017). Conclusion . A single-shot PENG block provides postoperative analgesic efficacy comparable to that of continuous epidural analgesia after primary THA, while offering better preservation of motor function and a lower incidence of hemodynamic complications.

26 August 2024 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
VMV. Yu. Medvedeva
V. Yu. Medvedeva
KKK. N. Khrapov
K. N. Khrapov
AKA. A. Khryapa
A. A. Khryapa
KKK. Yu. Kankova
K. Yu. Kankova
In cardiac surgery with cardiopulmonary bypass (CPB) is a common complication. The incidence of this complication in cardiac surgery patients is estimated at about 10%. For this reason, the introduction of a patient blood management (PBM) in cardiac surgery is extremely relevant. Antifibrinolytic therapy is a key pharmacological tool of a multimodal PBM in cardiac surgery with CPB. The use of antifibrinolytics (tranexamic acid (TXA) and epsilon aminocaproic acid (EACA)) is standard practice in complex cardiac surgery with CPB. However, there is currently ongoing discussion regarding the search for the optimal dose of EACA and TXA to achieve an effective concentration in blood plasma in order to inhibit fibrinolysis with the minimization of adverse events. The use of aprotinin has a number of potential advantages, but its use in routine clinical practice is significantly limited. This review presents modern approaches to antifibrinolytic therapy, examines the mechanisms of action of the main drugs, highlights the side effects associated with the use of antifibrinolytic agents.

17 December 2023 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
DAD. A. Averyanov
D. A. Averyanov
KKK. N. Khrapov
K. N. Khrapov
Fluoroscopy guided epidural injection is often used to treat radicular pain in the lumbar spine. Risk and effectiveness data vary depending on injection routes and underlying pathology. There are several options for accessing the epidural space in the lumbosacral spine to perform an analgesic injection – caudal, interlaminar and transforaminal. Transforaminal epidural injection is currently the most studied and widespread in the foreign practice of treating chronic pain. A brief overview describes transforaminal accesses to the epidural space of the lumbar spine and needles used for this purpose, lists possible adverse events and complications, and also provides a detailed illustrated description of supraneural transforaminal access.

27 June 2025 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
VMV. Yu. Medvedeva
V. Yu. Medvedeva
KKK. N. Khrapov
K. N. Khrapov
AKA. A. Khryapa
A. A. Khryapa
NMN. S. Molchan
N. S. Molchan
VPV. A. Pyzhov
V. A. Pyzhov
AZA. D. Zolottseva
A. D. Zolottseva
The objective was to compare the efficacy and safety of the use of aprotinin and tranexamic acid in cardiac surgery with cardiopulmonary bypass (CPB) in adult patients.Materials and methods. A randomized prospective comparative study was conducted. A total of 62 patients were included who underwent cardiac surgery with CPB. In order to prevent bleeding, fibrinolysis inhibitors were used intraoperatively in all patients, depending on the drug used, two groups were formed: «tranexamic acid» (n = 32) and «aprotinin» (n = 30). The time of the operation, the time of CPB and anoxia were recorded, postoperative blood loss according to 12-hour intervals and the need for transfusion during and after surgery were assessed. In the postoperative period, the need for inotropic support at the time of transfer to the intensive care unit (inotropic index), time of ALV, kidney (GFR, creatinine) and liver (ALT, direct bilirubin) function, as well as markers of the inflammatory response (white blood cell count, C-RP) were taken into account.Results. The volume of postoperative blood loss for 12 hours, as well as the need for transfusion in the intraoperative period, did not differ in the studied groups. At the same time, a decrease in the need for erythrocyte suspension was detected in the «aprotinin» group in the early postoperative period (p = 0.02). In the «aprotinin» group, the white blood cell count was higher than in the «tranexamic acid» group (p = 0.02), while the C-RP level was significantly lower in the “aprotinin” group (p = 0.002). The values of the PaO2 /FiO2 ratio in the studied groups did not differ, and the time of ALV was significantly lower in the «aprotinin» group (p = 0.016). Conclusion. The results of the study showed that the use of aprotinin during cardiac surgery with CPB reduces the need for transfusion of hemocomponents in the early postoperative period; no side effects were detected when using the drug.